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Abstract
Proteogenomic searching is a useful method for identifying novel proteins, annotating genes and
detecting peptides unique to an individual genome. The approach, however, can be laborious, as it
often requires search segmentation and the use of several unintegrated tools. Furthermore, many
proteogenomic efforts have been limited to small genomes, as large genomes can prove
impractical due to the required amount of computer memory and computation time. We present
Peppy, a software tool designed to perform every necessary task of proteogenomic searches
quickly, accurately and automatically. The software generates a peptide database from a genome,
tracks peptide loci, matches peptides to MS/MS spectra and assigns confidence values to those
matches. Peppy automatically performs a decoy database generation, search and analysis to return
identifications at the desired false discovery rate threshold. Written in Java for cross-platform
execution, the software is fully multithreaded for enhanced speed. The program can run on regular
desktop computers, opening the doors of proteogenomic searching to a wider audience of
proteomics and genomics researchers. Peppy is available at http://geneffects.com/peppy.
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Searching MS/MS data against a protein database is an established method for determining
the protein composition of a biological sample. However, as a protein database contains only
known proteins, the ability to discover new or altered proteins is limited. In the analysis of
diseases such as cancer, aberrant forms of expression may produce disease-related proteins
not found in the reference protein data sets;1 therefore, searching standard protein databases
(e.g., Uni-ProtKB/Swiss-Prot) will miss these cancer-related, novel proteins.
Proteogenomic searches have led to the discovery of novel coding regions, the determination
of correct start and stop positions of a gene, and the verification of splice variants. When
Castellana et al. performed a proteogenomic search of Arabidopsis thaliana,2 they found
778 new protein-coding genes, refined 695 existing gene annotations, and estimated that
13% of the A. thaliana annotated proteome was incomplete. In another large-scale
proteogenomic analysis, Payne et al. found nonannotated genes, corrected protein
boundaries and removed incorrect annotations of open reading frames (ORFs) for Yersinia
pestis KIM and 21 other Yersinia genomes, ultimately altering 141 incorrectly annotated
gene models of the bacteria.3
Further, as the speed of genome sequencing and its cost-effectiveness rapidly improve, the
resulting explosion of genomic data can vastly benefit the world of proteomics.4
Proteogenomic analysis using the subject’s genome that produced the biological sample can
potentially reveal phenotypic variants of peptides or entire proteins that are not normally
coded (e.g., their expression is the result of a drastic genomic alteration).
The Steps of a Proteogenomic Search
A proteogenomic search is largely similar to typical protein searches with a basic workflow
illustrated in Figure 1. The main difference from searching a reference protein database is
that the theoretical peptide database to which the spectra are compared is derived from an in
silico digestion of a six-frame translation of the full genome sequence and that the genomic
locus of every peptide must be tracked. A six-frame translation of a nucleotide sequence is
necessary because transcripts may start at any index on either strand of a chromosome. The
peptide-spectrum match (PSM) software compares the spectra against the theoretical peptide
database and returns a score for each match; there exist a plurality of options for this step.5
If this score is not a global confidence value (e.g., E-value, P-value), then such a value can
be assessed after the fact.6
False discovery rate (FDR) estimation is a critical final step in any proteogenomic (or
proteomic) search.7 False positive identifications are unavoidable but employing FDR
thresholds allows a researcher to control the true positive saturation of the resulting set of
PSMs. Several methods exist for estimating FDRs;8 we have elected to implement the
target-decoy strategy set forth by Elias and Gygi,9 which necessitates the creation of a decoy
of the six-frame translation.
The final output of a proteogenomic search is a table of PSMs that typically contains the
peptide’s amino acid sequence, identifying information for the spectrum (e.g., file name,
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locus within the file), a confidence score conveying the quality of the PSM and information
regarding the coding location of the given peptide (e.g., chromosome, strand, start and stop
loci). These results are often cross-referenced with a search on a standard protein database
so that the novel peptides can be immediately identified.10 The peptides not present within
the reference gene set suggest candidates of unannotated or incorrectly annotated genes.
Challenges for Implementation of Proteogenomic Searching
The primary hurdles of proteogenomic searches, as compared to protein database searches,
have little to do with the scientific complexities, but are a product of the logistics of the task.
Some of these logistics include issues of task segmentation to accommodate limited
computer memory, the need for different tools to perform the six-frame translation, peptide
loci mapping and FDR analysis.
As the protein-coding region of the human genome comprises ~1% of the nucleotide
content,11 it stands to reason that a peptide database derived from a six-frame translation
will be on the order of 600 times larger than one produced from a reference protein database.
This increased search space has presented challenges for implementation due to insufficient
computer memory. The solution we have implemented is to segment the genome into
manageable sections, search the full set of spectra within each set of peptides and combine
the individual results into one master results set. Peppy has been optimized to automatically
segment the genome and then reaggregate those segments, allowing for once-impossible
searching of genomes to be performed on regular desktop computers, in reasonable amounts
of time.
Furthermore, the generation of a six-frame translation of a genome is not always an
automated task. For example, the generation of a six-frame translation can be done via an
online tool such as the BCM Search Launcher;12 however, online tools are only useful for
short genomic sequences. Alternately, the translation can be done via a script such as the
Perl script included with the InsPecT software package.13 Though tools are available to
handle the translation of the genome, they require human operation, and the output of one
step may not easily integrate into the input of the next step. The lack of integration can cause
problems of human error, and in getting the data from disparate systems to ‘speak to’ one
another.
Reporting the genomic loci of a peptide typically entails a separate process wherein the
amino acid sequence must be analyzed by a tool to find the probable locations of its
encoding.14 Peppy negates the need for this extra step by retaining a peptide’s genomic
location as it is translated from the genome. This genomic coding location is associated with
the peptide throughout the proteogenomic search process, so the peptide’s location never
needs to be ‘found’. Mapping back to the peptide’s encoding locus is therefore an
unnecessary step.
Limited computer memory presents the primary challenge estimating false discovery rates
for six-frame searches. Common target/decoy FDR techniques call for concatenating the
decoy database with the reference database wherein the decoy proteins contain header
information identifying them as decoys.15 As a six-frame target/decoy database will be ~600
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times that of a reference protein target/decoy, measures for task segmentation are typically
required. However, this segmentation would then require extra steps to unify all results,
resolve instances of multiple peptide matches between result sets to a given spectrum, and
potentially complicate deriving peptide coding locations.
With each separate tool requiring human intervention, there is added time, complexity and
an increased chance for human error. In their survey of proteogenomics, Renuse et al.
addressed the lack of an integrated solution as a major hurdle for proteogenomic analysis.
Peppy is a single, integrated tool and the automation of these steps creates a streamlined
pipeline for data, from processing of genome files to final FDR analysis, negating the need
for separate tools to perform those functions and thereby reducing required effort and the
possibility of error.
MATERIALS AND METHODS
To use Peppy, the user must provide three input sources: (i) a directory containing all
spectral data, (ii) a directory containing genomic or proteomic sequences, and (iii) a user-
defined properties file. The properties that can be specified in this file are those familiar to
users of protein identification software, such as fragment tolerance, precursor tolerance, the
maximum number of missed cleavages in a generated peptide, etc.
Generating the Peptide Database
The first stage of Peppy’s execution is generating the collection of peptides from the
genome, i.e., creating the “peptide database”. This is accomplished via a six-frame
translation and in silico digestion of the sequence files. Whole genome proteogenomic
searching tasks often involve a peptide database so large that common desktop computers do
not have sufficient RAM to process it all at once. Peppy accommodates memory limitation
by performing the translation and digestion on segments of each chromosome. The number
of nucleotides in a given segment is user-adjustable to allow for a variety of memory
requirements. This segmentation produces manageable sets of peptides against which the
full set of spectra are searched. Results from each search are aggregated into a master results
list. A small number of nucleotides (120) overlap between the segments to account for
peptides that span the segment boundaries; redundant peptides created by this overlapping
process are eliminated in the final stage of PSM evaluation. Both the translation and
digestion processes are multithreaded to take advantage of the speed afforded by multicore
processors. Peptide loci with respect to the segment locus is resolved to global genomic start
and stop coordinates that are stored along with the peptides during the digestion stage. This
locus tracking renders the mapping of PSMs back to their genomic loci an automated
process.
Loading the Spectra
As the spectral files are loaded, measures are taken to track and filter them. Each spectrum is
assigned an MD5 hash algorithm identification string based on the peak mass and abundance
data of the spectrum. The MD5 can be used as an identifier that is independent of spectrum
name or file locus and can facilitate spectrum tracking when search results are merged into a
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unified database. After a spectrum is loaded and its MD5 hash has been generated, spectral
cleaning is applied. Intelligently reducing the number of peaks in a spectrum can
significantly reduce the time required to process the quality of a PSM, without negatively
impacting sensitivity. Spectral cleaning can also reduce false positives as noise peaks
increase the chances of erroneous alignments with theoretical ions.16 The built-in spectrum
cleaning method is similar to a technique employed by Ascore17 wherein a spectrum is
broken into 100 Da windows and the 10 most intense peaks for each window are retained.
We tested several mass window sizes and number of peaks to retain per window and found
that 100/10 increases positive identifications for many data sets. These values can be altered
within the properties file should the user require different settings.
Matching and Scoring Peptides to Spectra
Peppy contains a novel PSM scoring system18 that combines estimated P-values for ion
matches, above-median matched ion abundances and appropriate relative b- and y-ion
abundances. Also included with Peppy is an implementation of the PSM scoring system
found in Morpheus.19 Users may select which PSM scoring system is used for analysis by
designating this in the properties file. The Peppy source code uses a generic constructor
when instantiating PSM objects; this framework facilitates the efforts of developers
interested in crafting their own scoring system.
Peptide/spectrum matching and scoring is accomplished with parallel programming
techniques that fully exploit the power of multicore computers. Comparing a peptide to a
spectrum and assigning a score for that PSM is an event independent of all other peptide/
spectrum comparisons and scores. This process is easily parallelizable as it is not prone to
data synchronization issues. Parallelization is implemented via several worker threads all
controlled by a thread server. The number of available computer processors that are detected
by the software determines the number of worker threads. Thus, if the program is running on
an 8-core machine, 8 worker threads will be created. Figure 2 shows Peppy’s speed
performance vs the number of processor cores, using three separate data sets.
The function of the thread server is to marshal the division of labor among the worker
threads. The thread server gives each worker thread one spectrum and the entire collection
of peptides. A worker will search for the best scoring peptides for its given spectrum by
comparing that spectrum to every peptide within a given precursor tolerance window of a
spectrum’s precursor mass. As the peptide list is sorted by mass, this process is optimized by
using binary search to find the lowest and highest mass peptides within the desired precursor
tolerance then iteratively comparing the spectrum to every peptide between those indices
within the peptide list. The worker thread reports its findings back to the server and the
server assigns the worker thread a new spectrum to investigate. This process repeats until all
spectra have been processed.
False Discovery Rates
The central question for every peptide identification is: is this true? Did a particular amino
acid sequence produce the observed spectrum, or is the peptide/spectrum match merely a
product of coincidence? As previously mentioned, integrated into Peppy is the functionality
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to calculate false discovery rates for a given set of spectra using the target-decoy method
described by Elias and Gygi. The first step in FDR analysis is the creation of the decoy; an
ideal decoy database contains no true positives and mimics the characteristics of the target
database (e.g., cardinality, mass distribution, acid content and peptide length distribution).
The decoy peptide database is generated in a manner similar to that of the target database: a
six-frame translation of the genome is split into theoretical proteins along the stop codons.
The amino acid sequences of each theoretical protein are then reversed and in silico digested
according to the rules for the given protease. This creates a peptide database that is similar in
peptide count, amino acid content and peptide length distribution as that of the “target”
database, but has a low probability for containing a significant numbers of true peptides.
When a search is performed, Elias et al. stress that “competition” must exist between target
and decoy results such that only the best scoring match for any given spectrum is used for
the FDR calculation. With typical protein database searches, this is most easily
accomplished by appending the decoy to the target database. However, computer memory
constraints can be a limiting factor for this approach with a proteogenomic database;
therefore, database segmentation and results combination must be performed in a way that
produces the desired competition. To that end, the search results are reduced to only the top
match for every spectrum, which are then ordered by confidence score. If a decoy peptide
provides the best match for a given spectrum, then it is the one PSM entered into the list for
that spectrum. The FDR at each confidence threshold is calculated as two times the number
of passing decoy matches divided by the full set of passing matches.
To speed calculation, one may set the parameter of size of spectra subset to be used for FDR
calculation. If, for example, the body of spectra contains 1 000 000 files, a researcher may
elect to use a random subset of 10 000 so that FDR calculation will take about 1/100th of the
time, yet still remain statistically significant.20
EXPERIMENTAL PROCEDURE
Peppy was used for the creation of the ENCODE proteogenomic results;21 here we revisit
the proteogenomic analysis of the ENCODE Tier 1 cell line GM12878 with the aim of
demonstrating how proteogenomic searches can be used in conjunction with proteomic
searches as a first step to reveal instances of undocumented proteins/isoforms. While the
previous analysis mapped spectra to their probable coding locations in order to ascertain
protein expression, this analysis is focused on identifying subject-specific peptides and
potential instances of novel coding. This will be accomplished with two primary differences
in approach: (i) The previous genomic results were produced by searching only a six-frame
translation of hg19 (GRCh37). For this analysis, we incorporated a personalized protein
database and personalized genome by using the sequenced diploid genome NA12878.22
Searches were performed according to the process displayed in Figure 3 to incorporate both
maternal and paternal sequences so as to reveal which peptides are unique to, or that are
shared by the strands. (ii) To lend high confidence to the novel results, we employed
separate FDR analysis to the nonexonic matches.
The GM12878 spectral data set (available from http://giddingslab.org/data/encode/) contains
~1 million spectra; it was created using trypsin as the digestive enzyme and reversed-phase
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liquid chromatography MS/MS analysis performed on a nanoLC-Ultra system (Eksigent,
Dublin, CA) coupled with an LTQ Orbitrap Velos mass spectrometer (Thermo Scientific,
San Jose, CA). FDR analysis of the spectra using a liberal precursor tolerance (500 ppm)
revealed that 99% of the results at the 1% FDR fell within 40.41 ppm of the predicted
peptide mass. This precursor tolerance value was used for all successive searches.
We used the GENCODE v. 12 gene annotations23 as an instruction set for transcription/
translation of the NA12878 diploid genome to create personalized maternal and paternal
protein databases (“G12-M” and “G12-P”, respectively). The resulting custom databases
were very similar to the GENCODE reference database (G12) except that nsSNPs within the
maternal and paternal genomic sequences had been translated to amino acid variations in the
protein sequences. Creating these databases required producing a version of NA12878
aligned to the hg19 assembly. Using the hg18-based chain files included with NA12878, the
NA12878 sequences were reconstructed to conform to an hg18 assembly. Nucleotide
differences between the hg18-based NA12878 and hg18 were saved in a SNP file. The
genomic indices of the SNPs were lifted over to hg19 indices using the UCSC liftOver tool
(http://genome.ucsc.edu). The hg19-based SNPs were then overlaid onto hg19 to create a
version of NA12878 that conformed to the hg19 assembly.
Six-frame genome searches present a major challenge that we addressed in our analysis
pipeline. The challenge is that the vast majority of peptides populating six-frame databases
do not exist in nature, which increases the chances for false positive spectrum matches.
These false positives may “ride the coattails” of known peptides when estimating FDR,
leading to spurious inflation in the number of “novel” identifications. Put another way, if a
1% FDR threshold is set for proteogenomic search results and 1% of the results are to novel
peptides, how can we be sure the novel results are not the majority of the false positives? To
address this challenge, we adopted the technique of mass spectrum sequential subtraction
(MSSS)24 as our method for searching multiple proteomic and genomic databases. The
process involves searching proteomic and genomic databases in sequence with protein
database searches preceding the genomic. For each database searched, the 1% FDR was
estimated and all spectra identified at that cutoff were removed from the body of spectra
used in the next database search. In cases where estimating a 1% FDR was not possible
(e.g., there were fewer than 99 true positives), the ~0% FDR was used. Removing positively
identified spectra with each database search not only makes for faster searches, but also
neatly addresses the false positive conundrum for the novel, genome-only matches.
RESULTS
From the full body of spectra, 11.4% (117 991) were found to match G12. Subject-specific
sequences included 34 unique peptides (from 82 spectra) matched with G12-M, 40 unique
peptides (from 94 spectra) with G12-P. Of the peptides containing subject-specific acid
variations, 24 were shared between the two sets. Two separate hg19 searches were required
due to the fact that different sets of spectra were identified—and therefore removed—
following the maternal and paternal protein searches. Three unique peptides were identified
in the hg19 genome searches that were not found in the protein databases. No results were
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found that would indicate novel forms of expression tied specifically to the maternal or
paternal strands. The novel results are as follows:
• APAGSAAGEGLLPHR (chr7:48691991-48692036, hg19, reverse strand): The
peptide’s coding location maps to what was thought to be an intergenic region of
chr7. Sequence homologies for the peptide were investigated using the protein
BLAST tool;25 the sequence shares some similarity (11/15 acids) with a
subsequence of the bacterial protein leucyl-tRNA synthetase (YP_001505193.1).
The highest confidence peptide/spectrum alignment is displayed in Figure 4 and
shows significant mass ladder coverage to support this peptide sequence.
• AVAAAAAAAAAAAAAGGR (chr18:31158414-31158468, hg19, reverse
strand): Located ~70bp upstream of the annotated starting point for the ASXL3
transcript. The peptide implies an extended variation of that gene.
• NDDIPEQDSLGLSNLQK (chr20:10401214-10401265, hg19, reverse strand): is
located in the annotated 3′ UTR of MKKS. This sequence appears in an
unreviewed isoform of the gene (Uniprot Q9HB66), lending credence to that
isoform.
The novel matches found here demonstrate how proteogenomic searches can suggest
instances of incorrect or incomplete gene annotations. However, given the difficulty of
obtaining complete peptide coverage of a protein, these results are best taken as starting
points for further investigation. For example, the hypothetical novel protein on chr7 should
be confirmed via an orthogonal method such as transcript analysis in order to validate and
derive the full coding sequence.
DISCUSSION
Proteogenomic searching is quickly gaining traction as a common component of many
proteomic studies.10b,a,26 Until recently, computing resources for such tasks were significant
and proved to be a formidable barrier to entry. Improvements in computer technology have
made this kind of search a viable option, however the lack of a tool that unifies all necessary
tasks of such a search rendered the work unnecessarily complicated. We have presented
Peppy, an integrated proteogenomic search tool that automatically performs the most
common proteogenomic search tasks. Peppy’s charter is to be fast, accurate and to require as
little researcher intervention as possible.
A primary benefit of Peppy is its ability to easily search entire genomes, including the
human genome. Peppy is designed to take genome files in FASTA format, negating the need
for a predigest and six-frame translation using a separate tool. As genomic locus for each
peptide is tracked, a separate mapping tool is not needed. The automation of steps is
likewise a significant benefit as it increases usability while reducing the possibility for
human error. This is especially true of the automated segmentation of the genome into
portions small enough to be handled by the computer’s memory. Additionally, the important
step in determining the confidence of Peppy’s identifications—the FDR analysis—is built
into the system itself. The time and effort saved by an integrated proteogenomic system
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promotes the possibility of including proteogenomic searches as a standard component of
proteomic investigations.
Some Limitations of Six-Frame Searches
Though the possibility for discovering novel peptides is a major benefit of proteogenomic
searches, the method is not without its limitations. The high number of false positive
peptides present in a six-frame database creates the possibility for deceptively good
spectrum matches with incorrect peptides. Proper FDR analysis can control for the
saturation of false positives in the final result set, but the greater the number of high-quality
false positives, the higher the confidence threshold must be to ensure the desired FDR. This
higher confidence threshold then creates a higher degree of false negatives. Second, ~25%
of tryptic peptides span exon boundaries27 and these peptides will elude detection using
peptides generated from a straight six-frame translation. Therefore, we recommend using
proteogenomic searches in conjunction with standard proteomic searches in a manner akin
to the MSSS technique described above. False negatives, especially exon-spanning peptides,
will be reduced by including protein database searches; additionally the novel, non-exonic
matches found from the genome search will have higher confidence as their FDR estimates
will not include known proteins.
Future Work
We are presenting version 1.0 of the Peppy software: refinements are currently in
development that will improve the accuracy and usefulness of search results. The inclusion
of modifications such as post-translational modifications (PTMs), labels and selenocysteine
could greatly improve the number of true positives returned. However, their inclusion will
also increase the search space and therefore the chance of false positives, so we are
exploring some novel techniques to address this issue, while striving to maintain Peppy’s
speed capabilities.
Since the genome and spectral data sets are typically large, a cross-analysis of the two will
produce copious data, necessitating a way to navigate that data easily. Thus, efforts are
underway to facilitate integration with the UCSC Genome Browser as well as user-friendly
reports that combine the results from several proteogenomic experiments and provide
graphical representations of PSMs.
Given the heterogeneity of mass spectrometers, sample preparation techniques and analyses,
there is a need for the automatic discovery of optimal settings for mass tolerances, PTMs,
missed cleavages, etc. In the above analysis, we took measures to find an optimal precursor
tolerance using FDR analysis and efforts are in progress to automate this process. Further,
we aim to implement the use of the MSSS technique directly into the software as the process
of sequentially identifying spectra then removing them from subsequent searches is a rote
task that is ripe for automation. MSSS confers the benefits of both protein and six-frame
database searches while creating result sets that can be unified to a homogeneous FDR–
characteristics we feel many researchers will appreciate.
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The Peppy application, source code and documentation are available at http://
geneffects.com/peppy.
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The essential steps required in a six-frame search. Variations on the approach entail how to
segment the genome; what delineates a theorized protein; how to create a decoy database
and the method for estimating FDR.
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Time needed to complete a proteomic search vs the number of processors available to the
software. Tests were done on a 12-core machine, varying the number of cores used from 1 to
12. “Kapp”, “Aurum”, and “UPS50” are data sets with 517, 1349, and 1473 spectra,
respectively; the database searched was UniProt human.
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Proteogenomic analysis workflow of the GM12878 cell line spectra using the NA12878
diploid genome.
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Peptide/spectrum alignment for the sequence APAGSAAGEGLLPHR. Every amino acid is
delineated by at least one fragment ion.
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